Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03573206 · ClinicalTrials.gov registry record · NA

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

A NA study of Surgical Wound, sponsored by Cardiva Medical.

Completed
Registry status
NA
Development phase
168
Enrollment target
3
Study locations

NCT03573206 is a NA study of Surgical Wound that has completed, run by Cardiva Medical. The registered enrollment target is 168 participants, above the 86-participant average among 17 other Surgical Wound trials with a reported enrollment target (95% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03573206, a NA study of Surgical Wound, has completed, sponsored by Cardiva Medical.

COMPLETED
Registry status
NA
Development phase
168 participants
Enrollment target
3
Study locations

Study Summary

The objective of the trial is to demonstrate the safety and effectiveness of the Cardiva Mid-Bore Venous Vascular Closure System (VVCS) in sealing femoral venous access sites at the completion of catheter-based procedures performed through 6-12 Fr introducer sheath, while allowing for one or more of the following: elimination of the Foley catheter, elimination of protamine, or allowing same (calendar) day discharge for the appropriate patient population.

Conditions Studied

Interventions

  • DEVICE Cardiva Mid-Bore Venous Vascular Closure Device (VVCS)

Study Locations (3)

Georgia

  • Emory St. Joseph's Hospital - Atlanta

New Jersey

  • Valley Hospital - Ridgewood

Texas

  • Texas Cardiac Arrhythmia Research Foundation - Austin

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2018-08-27
Est. Completion 2019-03-31
Phase NA

Sponsor

Cardiva Medical

5 total trials

What the Registry Record Tells You About NCT03573206

The ClinicalTrials.gov registry entry for NCT03573206 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 86-participant average among 17 other Surgical Wound trials with a reported enrollment target (95% higher). The listed sponsor is Cardiva Medical, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which Cardiva Mid-Bore Venous Vascular Closure Device (VVCS) is the first listed.

NCT03573206 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Georgia, New Jersey, Texas.

Frequently Asked Questions

What is clinical trial NCT03573206 about?

NCT03573206 is a clinical study titled "AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)". The objective of the trial is to demonstrate the safety and effectiveness of the Cardiva Mid-Bore Venous Vascular Closure System (VVCS) in sealing femoral venous access sites at the completion of catheter-based procedures performed through 6-12 Fr introducer sheath, while allowing for one or more of...

What is the current status of trial NCT03573206?

This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2018-08-27. Estimated completion is 2019-03-31.

What conditions does trial NCT03573206 study?

This clinical trial studies the following conditions: Surgical Wound.

What interventions are being tested in trial NCT03573206?

The interventions under investigation include: Cardiva Mid-Bore Venous Vascular Closure Device (VVCS) (DEVICE).

Who is sponsoring clinical trial NCT03573206?

This trial is sponsored by Cardiva Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03573206 being conducted?

This trial has 3 study locations across Georgia, New Jersey, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Wound

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.